2025-07-24: DEUSG Virtual

Meeting Details

Date & Time: Thursday 24th July, 2025. 11am UTC

Objectives

Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees: Alejandro Lopez Osornio Monica Harry Yongsheng Gao Nicola Ingram Mia van Dorp Achyut Patil (Unlicensed) Aditya Parnandi (Unlicensed) ana.paredes (Deactivated) @Benny van Bruwaen Betania Arispe (Unlicensed) Claudie Sombie (Deactivated)Dion McMurtrie Colin Macfarlane (Unlicensed) Émilie NGUYEN (Unlicensed) francois.lavoie (Unlicensed) @Ger Gahan Guillermo Reynoso Hui Pheng Teoh (Unlicensed) Jaya Sonavane (Unlicensed) Justin Stout (Unlicensed) Joanna Hand Julie Boutin Karen Rees Krista Lilly Yongsheng Gao Linda Bird (Unlicensed) Oumaima Kharrat (Unlicensed) Marie-Alexandra Lambot @maria gomez Michael Keary @nick mcgraw Noelle Horan (Unlicensed) Olivia Dalleur (Unlicensed) Paul Wright Robert Wynne (Unlicensed) Stuart Abbott (Unlicensed) Tara Kelly (Unlicensed) Wei Zhou (Unlicensed) Yolaine Forget (Unlicensed)

Zoom Link

Meeting Recording

Recording: https://snomed.zoom.us/rec/share/ZIOr6Z49IpZ20n8HN8t-Q2YVMUcyp4GJSb13NvLeM29DFWmx-5AV5wCE6rkWv84w.-4Yqr9rPkUQaijoI

Passcode: $tokT5pk

Discussion items

Item	Description	Mins	Owner	Notes & Actions

Item	Description	Mins	Owner	Notes & Actions
1	Opening	2	Alejandro Lopez Osornio	Welcome & Notification of Recording
2	Substances Co-Ordination	10	Krista Lilly	Workshop/Clinic to support queries from countries currently undergoing reviews in advance of promotion. Policies related to substance submissions during this project. Medication Substances Project 2025/2026
3	Implementation of Routes of Administration for medicines	15	Mia van Dorp	Update from New Zealand on Implementation of Routes of Administration Presentation:
4	Editorial advice for PCDs PTs	10	Alejandro Lopez Osornio Karen Rees	Consultation received from members about improving the guidance on this topic
5	Drug Administration vs Therapy	10	Nicola Ingram	Highlight discussion topic
6	AOB	2	Alejandro Lopez Osornio	Prioritize backlog for next steps Next meeting: August 7th, 2025 Antwerp 2025: DEUSG meeting is currently scheduled for Monday October 20th. See timetable: October 2025 - SNOMED International Business Meetings SNOMED Expo Programme released.
7	Topic Backlog			Less Granular Clinical Drug Elemental Substances (Matt, AUS) Substances Co-ordination Step 1: Substances in multiple extensions Batch promotions complete, SI review and authoring underway Step 2: Substances in one extension Step 3: Ongoing Substance Co-ordination (capturing at regulator level) Medication Stopped v Medication Discontinued (Karen, SI) Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work + ES) Value range of a \|Has container type\| attribute (Linda, CA) Top level children of 373873005 \|Pharmaceutical / biologic product\| hierarchy - are members using/how are members using? (AUS) Routes of Administration - Implementation Considerations (Mia, NZ) Increase range of has active ingredient to include microorganisms and natural products (Guillermo) Link between Substances and the organism they come from (Cat dander protein → Cat organism) see PCP-68 Done or in progress: Hydration Subsumption 'Option 3' proposed by DEUSG for communication/consultation with MAG and EAG Group Input on Patch Strength Representation Briefing note now being implemented Dose Form Intended Site v Route of Administration (BEL) Pending implementation use-cases associated with intended site Drug extension MRCM attributes (CA, AUS) SI facilitating links with CA and AUS for cross-promotion, next steps: other countries to be invited to add to catalogue

There are currently no attachments on this page.